Testosterone, dihydrotestosterone and estradiol are differentially associated with carotid intima-media thickness and the presence of carotid plaque in men with and without coronary artery disease

Endocrine Journal

Volumn 62, Issue 9, 2015, Pages 777-786

  Chan, Yi X ^a,b   Knuiman, Matthew W ^c   Hung, Joseph ^a,d   Divitini, Mark L ^c   Handelsman, David J ^e   Beilby, John P ^c,d   McQuillan, Brendan ^a,d   Yeap, Bu B ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FIONA STANLEY HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

Carotid atheroma; Dihydrotestosterone; Estradiol; Intima media thickness; Testosterone

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; TESTOSTERONE;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEASUREMENT ACCURACY; PREVALENCE; RISK FACTOR; SEX HORMONE DETERMINATION; TANDEM MASS SPECTROMETRY; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASE; COMPLICATION; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; DIHYDROTESTOSTERONE; ESTRADIOL; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; TESTOSTERONE; YOUNG ADULT;

EID: 84942846857     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ15-0196     Document Type: Article

References (39)

1. Feldman HA, Longcope C, Derby CA, Johannes C, Araujo AB, et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2014) Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 129: 399-410.
3. Yeap BB, Araujo AB, Wittert GA (2012) Do low testosterone levels contribute to ill-health during male ageing? Crit Rev Clin Lab Sci 49: 168-182.
4. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, et al. (2011) Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endorcinol Metab 96: 3007-3019.
5. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, et al. (2010) Adverse events associated with testosterone administration. N Engl J Med 363: 109-122.
6. Srinivas-Shankar U, Roberts SA, Connolly MJ, O’Connell MD, Adams JE, et al. (2010) Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95: 639-650.
7. Ruige JB, Ouwens DM, Kaufman JM (2013) Beneficial and adverse effects of testosterone on the cardiovascular system in men. J Clin Endocrinol Metab 98: 4300-4310.
8. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459-467.
9. Inaba Y, Chen JA, Bergmann SR (2012) Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 220: 128-133.
10. Makinen J, Jarvisalo MJ, Pollanen P, Perheentupa A, Irjala K, et al. (2005) Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45: 1603-1608.
11. Svartberg J, von Muhlen D, Mathiesen E, Joakimsen O, Bønaa KH, et al. (2006) Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259: 576-582.
12. Farias JM, Tinetti M, Khoury M, Umpierrez GE (2014) Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab 99: 4698-4703.
13. Vikan T, Johnsen SH, Schirmer H, Njølstad I, Svartberg J (2009) Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur J Epidemiol 24: 289-295.
14. Dorr M, Wallaschofski H, Friedrich N (2009) Association of low total testosterone levels and prevalent carotid plaques: result of the study of health in Pomerania. Eur J Epidemiol 24: 389-391.
15. Brand JS, den Ouden ME, Schuurmans MJ, Bots ML, van der Schouw YT (2013) Endogenous sex hormones and subclinical atherosclerosis in middle-aged and older men. Int J Cardiol 168: 574-576.
16. Eller NH, Netterstrom B, Allerup P (2005) Progression in intima media thickness--the significance of hormonal biomarkers of chronic stress. Psychoneuroendocrinology 30: 715-723.
17. Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, et al. (2010) The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab 95: 3955-3964.
18. Tivesten A, Hulthe J, Wallenfeldt K, Wikstrand J, Ohlsson C, et al. (2006) Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol Metab 91: 4433-4437.
19. Fukui M, Kitagawa Y, Kamiuchi K, Hasegawa G, Yoshikawa T, et al. (2008) Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus. Metabolism 57: 285-289.
20. (1973) The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. JAMA 226: 652-657.
21. Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, et al. (2005) Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab 90: 5928-5936.
22. Handelsman DJ, Newman JD, Jimenez M, McLachlan R, Sartorius G, et al. (2014) Performance of direct estradiol immunoassays with human male serum samples. Clin Chem 60: 510-517.
23. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J (1999) Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 99: 2383-2388.
24. McCaskie PA, Beilby JP, Chapman CM, Hung J, McQuillan BM, et al. (2007) Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease. Hum Genet 121: 401-411.
25. Ly LP, Sartorius G, Hull L, Leung A, Swerdloff RS, et al. (2010) Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf) 73: 382-388.
26. Fukui M, Kitagawa Y, Nakamura N, Kadono M, Mogami S, et al. (2003) Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. Diabetes care 26: 1869-1873.
27. De Pergola G, Pannacciulli N, Ciccone M, Tartagni M, Rizzon P, et al. (2003) Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. Int J Obes Relat Metab Disord 27: 803-807.
28. Tsujimura A, Yamamoto R, Okuda H, Yamamoto K, Fukuhara S, et al. (2012) Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men. Endocr J 59: 809-815.
29. van den Beld AW, Bots ML, Janssen JA, Pols HAP, Lamberts SW, et al. (2003) Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157: 25-31.
30. Finkelstein JS, Lee H, Burnett-Bowie SM, Pallais JC, Yu EW, et al. (2013) Gonadal steroids and body composition, strength and sexual function in men. N Engl J Med 369: 1011-1022.
31. Tenenbaum A, Klempfner R, Fisman EZ (2014) Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol 13: 159.
32. Kannel WB, Vasan RS (2009) Triglycerides as vascular risk factors: new epidemiologic insights for current opinion in cardiology. Curr Opin Cardiol 24: 345-350.
33. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C (1999) Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84: 813-819.
34. Shchelkunova TA, Morozov IA, Rubtsov PM, Samokhodskaya LM, Andrianova IV, et al. (2013) Changes in levels of gene expression in human aortal intima during atherogenesis. Biochemistry (Mosc) 78: 463-470.
35. McRobb L, Handelsman DJ, Heather AK (2009) Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endorinology 150: 841-848.
36. Abbott RD, Launer LJ, Rodriguez BL, Ross GW, Wilson PW, et al. (2007) Serum estradiol and risk of stroke in elderly men. Neurology 68: 563-568.
37. Nofer JR (2012) Estrogens and atherosclerosis: insights from animal models and cell systems. J Mol Endocrinol 48: R13-R29.
38. Qiu Y, Yanase T, Hu H, Tanaka T, Nishi Y, et al. (2010) Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development. Endocrinology 151: 3307-3316.
39. Yeap BB, Alfonso H, Chubb SA, Handelsman DJ, Hankey GJ, et al. (2014) In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab 99: E9-E18.